Outcome of "indefinite for dysplasia" in inflammatory bowel disease: correlation with DNA flow cytometry and other risk factors of colorectal cancer.

[1]  D. Rubin,et al.  Outcome after surveillance of low‐grade and indefinite dysplasia in patients with ulcerative colitis , 2010, Inflammatory bowel diseases.

[2]  R. McLeod,et al.  Position Statement on the Diagnosis and Management of olorectal Neoplasia in Inflammatory Bowel Disease , 2022 .

[3]  D. Faigel,et al.  ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. , 2006, Gastrointestinal endoscopy.

[4]  Noam Harpaz,et al.  Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. , 2004, Gastroenterology.

[5]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[6]  Noam Harpaz,et al.  Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. , 2003, Gastroenterology.

[7]  K Abrams,et al.  Inter‐observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis , 2001, The Journal of pathology.

[8]  J. Satsangi,et al.  Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? , 2001, Gut.

[9]  K. Abrams,et al.  Colorectal cancer prevention in ulcerative colitis: a case‐control study , 2000, Alimentary pharmacology & therapeutics.

[10]  A. Ekbom,et al.  Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study , 1998, Gut.

[11]  G. Papatheodoridis,et al.  Indefinite Dysplasia in Ulcerative Colitis Has Little Clinical Significance and Is Not Associated With p53 Protein Accumulation , 1998, American Journal of Gastroenterology.

[12]  D. Sachar,et al.  Cancer in Crohn's disease: dispelling the myths. , 1994, Gut.

[13]  C. Williams,et al.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. , 1994, Gastroenterology.

[14]  P. Prior,et al.  Crohn's disease and colorectal cancer. , 1994, Gut.

[15]  Brian H. Mayall,et al.  Guidelines for implementation of clinical DNA cytometry , 1993 .

[16]  M. Kimmey,et al.  DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. , 1992, Gastroenterology.

[17]  P. Rabinovitch,et al.  Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. , 1992, Gastroenterology.

[18]  T. Caspersson,et al.  Comparative DNA analyses in longstanding ulcerative colitis with aneuploidy. , 1989, Gut.

[19]  G. Roos,et al.  DNA content and mucosal dysplasia in ulcerative colitis , 1989, Diseases of the colon and rectum.

[20]  A. Price,et al.  Observer variation in the assessment of dysplasia in ulcerative colitis , 1988, Histopathology.

[21]  R. Löfberg,et al.  Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? , 1987, Gut.

[22]  A. Öst,et al.  Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. , 1986, Gut.

[23]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.